CAR-T Cell Therapy is transforming cancer treatment through personalized immunotherapy approaches that harness the body’s own immune system to target and destroy cancer cells. This session will explore recent advancements in Chimeric Antigen Receptor T-cell engineering, innovative therapeutic strategies, and the expanding clinical applications of CAR-T therapies in hematologic malignancies and solid tumors. Discussions will focus on improving treatment efficacy, minimizing toxicity, overcoming resistance mechanisms, and enhancing patient outcomes through next-generation cell therapies. Experts will also address manufacturing challenges, regulatory considerations, and future directions in adoptive cellular immunotherapy. The session aims to provide comprehensive insights into the rapidly evolving landscape of CAR-T research and its role in precision cancer medicine.
Sub tracks:
CAR-T Cell Therapy Conferences